Previous Chapter Chapter 25: European Markets for Electrophysiology Mapping and Ablation Devices Next Chapter
Chapter 25: European Markets for Electrophysiology Mapping and Ablation Devices
[Page 219]The European electrophysiology (EP) mapping and ablation market was valued at over $190 million in 2005 and will increase at a compound annual growth rate (CAGR) of approximately 10% over the forecast period. Newer advanced diagnostic and ablation catheters, which are able to diagnose and treat complex arrhythmias, will drive EP market revenues over the next 5 years. Growth in revenue will also occur as catheter ablation becomes the standard treatment of supraventricular tachycardias (SVTs).
As arrhythmias become better understood, fewer standalone, diagnostic only electrophysiology studies (EPSs) will be performed because less invasive methods of diagnosis can be used. Compounding declining EPS growth are ...